Help us fund research to slow, stop and reverse Parkinson’s.

Drug Repurposing in Parkinson's

Given the number of failures and the ever-increasing costs and lengthy processes for drug development, our attention continues to be focused on utilising existing compounds approved for other conditions as novel treatments for Parkinson’s...


Author: Jessica Wright

Stem Cell Therapies - Research Updates

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.


Author: Jessica Wright

1st Day of Advent...

Listen to CPT's late Co-founder and President Tom Isaacs' rendition of 'The First Day of Christmas...' and see more of our Christmas advent review here...


Author: Jessica Wright

Latest news

  • **Webinar** - Targeting the Genetics of Parkinson's

    In this third in our collaborative webinar series with the Journal of Parkinson's and Parkinson's Movement, Professor Patrik Brundin, Dr Gaurav Gupta, Dr Ziv Gan-or Dr Roy Alcalay, Jonathon Silverstein and Ben Stecher discuss the genetics of Parkinson's... Read more

  • New Sub-types of Parkinson's Proposed

    A UK-wide study involving over 2500 people with recently diagnosed Parkinson's has identified four novel 'clusters' or groupings based on their clinical features. Read more

  • A Vaccine for Parkinson's - Developments in Immunotherapy

    When misfolded, the protein alpha-synuclein becomes toxic to neurons and is a key pathological culprit in Parkinson’s. It is therefore an important target for disease-modification. Immunotherapy in Parkinson's attempts to use immune cells, and specifically the antibodies they generate, to target misfolded alpha-synuclein to inactivate it. Read more

Latest events